Chen; Xiao-Tao

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; Xiao-Tao.The latest application filed is for "opioid receptor ligands and methods of using and making same".

Company Profile

2.27.33

Chen; Xiao-Tao - Furlong PA
Chen; Xiao Tao - Newark DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Opioid Receptor Ligands And Methods Of Using And Making Same App 20220175747 - Yamashita; Dennis ; et al.	2022-06-09
Opioid receptor ligands and methods of using and making same Grant 11,077,098 - Yamashita , et al. August 3, 2	2021-08-03
Opioid receptor ligands and methods of using and making same Grant 10,588,898 - Yamashita , et al.	2020-03-17
Opioid Receptor Ligands And Methods Of Using And Making Same App 20190343819 - Yamashita; Dennis ; et al.	2019-11-14
Opioid Receptor Ligands And Methods Of Using And Making Same App 20180311222 - Yamashita; Dennis ; et al.	2018-11-01
Opioid receptor ligands and methods of using and making same Grant 9,849,119 - Yamashita , et al. December 26, 2	2017-12-26
Opioid Receptor Ligands And Methods Of Using And Making Same App 20170326124 - Yamashita; Dennis ; et al.	2017-11-16
Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof App 20170298094 - Yamashita; Dennis ; et al.	2017-10-19
Opioid receptor ligands and methods of using and making same Grant 9,642,842 - Yamashita , et al. May 9, 2	2017-05-09
Beta-arrestin effectors and compositions and methods of use thereof Grant 9,534,017 - Yamashita , et al. January 3, 2	2017-01-03
Opioid Receptor Ligands And Methods Of Using And Making Same App 20160250199 - Yamashita; Dennis ; et al.	2016-09-01
Opioid receptor ligands and methods of using and making same Grant 9,309,234 - Yamashita , et al. April 12, 2	2016-04-12
Opioid Receptor Ligands And Methods Of Using And Making Same App 20150246904 - Yamashita; Dennis ; et al.	2015-09-03
Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof App 20150166604 - Yamashita; Dennis ; et al.	2015-06-18
Opioid receptor ligands and methods of using and making same Grant 9,044,469 - Yamashita , et al. June 2, 2	2015-06-02
Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof App 20150105316 - Yamashita; Dennis ; et al.	2015-04-16
.beta.-arrestin effectors and compositions and methods of use thereof Grant 8,993,511 - Yamashita , et al. March 31, 2	2015-03-31
Beta-arrestin effectors and compositions and methods of use thereof Grant 8,946,142 - Yamashita , et al. February 3, 2	2015-02-03
Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof App 20140357562 - Yamashita; Dennis ; et al.	2014-12-04
Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof App 20140336123 - Yamashita; Dennis ; et al.	2014-11-13
Opioid receptor ligands and methods of using and making same Grant 8,835,488 - Yamashita , et al. September 16, 2	2014-09-16
.beta.-arrestin effectors and compositions and methods of use thereof Grant 8,809,260 - Yamashita , et al. August 19, 2	2014-08-19
.beta.-arrestin effectors and compositions and methods of use thereof Grant 8,796,204 - Yamashita , et al. August 5, 2	2014-08-05
Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof App 20140005114 - Yamashita; Dennis ; et al.	2014-01-02
Opioid Receptor Ligands and Methods of Using and Making Same App 20130331408 - Yamashita; Dennis ; et al.	2013-12-12
Beta-arrestin Effectors And Compositions And Methods Of Use Thereof App 20130274176 - Yamashita; Dennis ; et al.	2013-10-17
Beta-Arrestin Effectors and Compositions and Methods of Use Thereof App 20130196902 - Yamashita; Dennis ; et al.	2013-08-01
.beta.-arrestin effectors and compositions and methods of use thereof Grant 8,486,885 - Yamashita , et al. July 16, 2	2013-07-16
Opioid Receptor Ligands And Methods Of Using And Making Same App 20120245181 - Yamashita; Dennis ; et al.	2012-09-27
Beta-Arrestin Effectors And Compositions And Methods Of Use Thereof App 20100184701 - Yamashita; Dennis ; et al.	2010-07-22
Met kinase inhibitors Grant 7,547,782 - Borzilleri , et al. June 16, 2	2009-06-16
Fused heterocyclic kinase inhibitors Grant 7,439,246 - Borzilleri , et al. October 21, 2	2008-10-21
Substituted 1,3-dihydro-imidazol-2-one and 1,3-dihydro-imidazol-2-thione derivatives as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme (TACE) Grant 7,211,671 - Sheppeck , et al. May 1, 2	2007-05-01
MET kinase inhibitors App 20070078140 - Borzilleri; Robert M. ; et al.	2007-04-05
Pyrrolotriazine kinase inhibitors Grant 7,173,031 - Borzilleri , et al. February 6, 2	2007-02-06
.alpha.-O-linked glycoconjugates, methods of preparation and uses thereof Grant 7,160,856 - Danishefsky , et al. January 9, 2	2007-01-09
Fused heterocyclic kinase inhibitors App 20060211695 - Borzilleri; Robert M. ; et al.	2006-09-21
Modulators of the glucocorticoid receptor and method Grant 6,995,181 - Vaccaro , et al. February 7, 2	2006-02-07
Pyrrolotriazine kinase inhibitors App 20060004006 - Borzilleri; Robert M. ; et al.	2006-01-05
Fused heterocyclic kinase inhibitors App 20050288290 - Borzilleri, Robert M. ; et al.	2005-12-29
Spiro-cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. converting enzyme (TACE) Grant 6,962,938 - Ott , et al. November 8, 2	2005-11-08
Modulators of the glucocorticoid receptor and method App 20050171136 - Vaccaro, Wayne ; et al.	2005-08-04
1,1-disubstituted cyclic inhibitors of matrix metalloproteases and TNF-.alpha. Grant 6,825,215 - Chen , et al. November 30, 2	2004-11-30
Modulators of the glucocorticoid receptor and method App 20040132758 - Vaccaro, Wayne ; et al.	2004-07-08
Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE) App 20040132693 - Ott, Gregory R. ; et al.	2004-07-08
Trimeric antigenic O-linked glycopeptide conjugates, methods of preparation and uses thereof App 20040102607 - Danishefsky, Samuel J. ; et al.	2004-05-27
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- .alpha. converting enzyme (TACE) Grant 6,740,649 - Ott , et al. May 25, 2	2004-05-25
Spiro-cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. converting enzyme (TACE) Grant 6,720,329 - Ott , et al. April 13, 2	2004-04-13
.alpha.-O-linked glycoconjugates, methods of preparation and uses thereof Grant 6,660,714 - Danishefsky , et al. December 9, 2	2003-12-09
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) App 20030139388 - Ott, Gregory R. ; et al.	2003-07-24
Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE) App 20030087882 - Ott, Gregory R. ; et al.	2003-05-08
Alpha-o-linked glycoconjugates, methods of preparation and uses thereof App 20030083235 - Danishefsky, Samuel J. ; et al.	2003-05-01
1,1-Disubstituted cyclic inhibitors of matrix metalloproteases and TNF-alpha App 20020137734 - Chen, Xiao-Tao ; et al.	2002-09-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.